Menu
Menu
The hearing explored the impact of the U.S. corporate tax code on foreign acquisitions of U.S. businesses and the ability of U.S. businesses to expand by acquisition.
Majority Report – Impact on the U.S. Tax Code on the Market for Corporate Control and Jobs
Chairman of the Board and Chief Executive Officer (1998-2015)
Allergan, Inc.
Vice Chairman (October 2009-February 2013) Chief Financial Officer (1993-2010)
Emerson
Chief Financial Officer (December 2011-June 2015) Board of Directors (September 2012-Present)
Valeant Pharmaceuticals International, Inc.